All Business articles
View all stories of the same content type.
-
BusinessChromosol’s silicon photonics system tackles data transfer bottleneck
Technology for integrating lasers directly into photonic circuits could accelerate replacement of large and expensive optical systems
-
Business
Polar storm paralyses US Gulf Coast petrochemical sector
Days after ‘icepocalypse’ hit Texas, 75% of US ethylene capacity was still offline, as was 70% of its polypropylene and 40% of propylene production
-
Business
Coronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
Business
BASF tightens austerity belt and closes plant in north of England
Political fallout over £1 billion Covid loan that preceded hexamethylene diamine plant closure
-
Business
Biggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
Business
Covid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
Business
Patent applications listing AI as an inventor run into legal problems
Artificial intelligence is increasingly being used to find new chemical compounds and repurpose drugs, but should laws be updated to protect the intellectual property of such discoveries?
-
Business
Hoxton Farms grows animal fat for meat substitutes
Covid-19 pandemic motivated friends to combine their expertise in cell biology and mathematical modelling, and realise company they had being discussing for years
-
Business
DuPont and spinoffs reach $4bn settlement to resolve PFAS liability issues
DuPont, Chemours and Corteva have also reached an $83mn agreement to settle 95 pending personal injury cases in Ohio related to PFAS
-
Business
Can chemistry thaw the vaccine cold chain?
Covid-19 has highlighted the challenges of storing vaccines at their proper temperature. Angeli Mehta explores how scientists are trying to protect vaccines from heat degradation
-
Business
Vaccine approvals offer hope as global Covid cases surge
A handful of vaccines are now approved and the first doses are being given to patients, with trials for many more candidates nearing completion
-
Business
Industry expects problems ahead after initial relief over Brexit deal
Uncertainty still looms over regulation and logistics
-
Business
Chaos on Capitol Hill prompts changes in pharma and biotech
Dow won’t donate to lawmakers who refused to certify presidential votes, others like 3M, Amgen, BIO and PhRMA pause political giving to reassess
-
Business
Chemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Business
Cybercriminals target Covid-19 vaccines
Officials in the UK and US warn of threat from cyber-attacks that steal data related to Covid-19 vaccines and aim to disrupt the supply chain
-
Business
AstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
Business
Pfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
Business
Fatal explosion at US chemical plant
Blast at Optima facility killed one and injured three others
-
Business
Oxford Biotrans makes its grapefruit compound out of oranges
Using their patented enzymes, Oxford Biotrans’ mission is to create new routes to useful chemicals – starting with their natural-grade food and fragrance products
